Author Name Patrick Ouellette
As evidenced by the recent announcement of its medical device and cybersecurity workshop on October 21 and 22, 2014, Food and Drug Administration (FDA) is taking medical device cybersecurity seriously. This stance is further supported by the FDA’s partnership with the National Health Information Sharing and Analysis Center (NH-ISAC) to identify, mitigate, and prevent medical device cybersecurity threats.
The FDA, which has has medical device regulation authority under the “Federal Food, Drug, and Cosmetic Act,” will work with the NH-ISAC to foster collaboration among healthcare providers and security experts. Deb Kobza, Executive Director of NH-ISAC, told HealthITSecurity.com last year that the organization’s goal is to make cybersecurity intelligence information actionable for participants. With offerings such as the First Responder Program and the National Healthcare and Public Health Cyber Response System, as well as a relationship with the Department of Health and Human Services (HHS), the NH-ISAC’s partnership with the FDA can be valuable to the healthcare industry.
The memorandum of understanding between the NH-ISAC and FDA had these goals in mind: